The role and impact of alternative polyadenylation and miRNA … – Nature.com

Domcke, S. et al. Evaluating cell lines as tumour models by comparison of genomic profiles. Nat. Commun. 4, 2126 (2013).

Article ADS PubMed Google Scholar

Kbel, M. et al. Ovarian carcinoma subtypes are different diseases: Implications for biomarker studies. PLoS Med. 5(12), e232 (2008).

Article PubMed PubMed Central Google Scholar

Soslow, R. A. Histologic subtypes of ovarian carcinoma: An overview. Int. J. Gynecol. Pathol. 27(2), 161172 (2008).

PubMed Google Scholar

Ip, C. K. M. et al. Stemness and chemoresistance in epithelial ovarian carcinoma cells under shear stress. Sci. Rep. 6, 26788 (2016).

Article ADS CAS PubMed PubMed Central Google Scholar

Galluzzi, L. et al. Systems biology of cisplatin resistance: Past, present and future. Cell Death Dis. 5(5), e1257e1257 (2014).

Article CAS PubMed PubMed Central Google Scholar

Seborova, K. et al. Association of ABC gene profiles with time to progression and resistance in ovarian cancer revealed by bioinformatics analyses. Cancer Med. 8(2), 606616 (2019).

Article CAS PubMed PubMed Central Google Scholar

Sharom, F. J. ABC multidrug transporters: structure, function and role in chemoresistance. Pharmacogenomics 9(1), 105127 (2008).

Article CAS PubMed Google Scholar

Smida, M. & Nijman, S. Functional drug-gene interactions in lung cancer. Expert Rev. Mol. Diagn. 12(3), 291302 (2012).

Article CAS PubMed Google Scholar

Shanker, S. et al. Drug resistance in lung cancer. Lung Cancer: Targets Ther. 1, 2336 (2010).

CAS Google Scholar

Chung, F. S. et al. Disrupting P-glycoprotein function in clinical settings: What can we learn from the fundamental aspects of this transporter?. Am. J. Cancer Res. 6(8), 15831598 (2016).

CAS PubMed PubMed Central Google Scholar

Derti, A. et al. A quantitative atlas of polyadenylation in five mammals. Genome Res. 22(6), 11731183 (2012).

Article CAS PubMed PubMed Central Google Scholar

Shi, Y. Alternative polyadenylation: New insights from global analyses. RNA 18(12), 21052117 (2012).

Article CAS PubMed PubMed Central Google Scholar

Reyes, A. & Huber, W. Alternative start and termination sites of transcription drive most transcript isoform differences across human tissues. Nucleic Acids Res. 46(2), 582592 (2017).

Article PubMed Central Google Scholar

Mandel, C., Bai, Y. & Tong, L. Protein factors in pre-mRNA 3-end processing. Cell. Mol. Life Sci. 65(78), 10991122 (2008).

Article CAS PubMed PubMed Central Google Scholar

Danckwardt, S., Hentze, M. W. & Kulozik, A. E. 3 end mRNA processing: Molecular mechanisms and implications for health and disease. EMBO J. 27(3), 482498 (2008).

Article CAS PubMed PubMed Central Google Scholar

Neilson, J. R. & Sandberg, R. Heterogeneity in mammalian RNA 3 end formation. Exp. Cell Res. 316(8), 13571364 (2010).

Article CAS PubMed PubMed Central Google Scholar

Chekulaeva, M., Hentze, M. W. & Ephrussi, A. Bruno acts as a dual repressor of oskar translation, promoting mRNA oligomerization and formation of silencing particles. Cell 124(3), 521533 (2006).

Article CAS PubMed Google Scholar

Berkovits, B. D. & Mayr, C. Alternative 3 UTRs act as scaffolds to regulate membrane protein localization. Nature 522(7556), 363367 (2015).

Article ADS CAS PubMed PubMed Central Google Scholar

An, J. J. et al. Distinct role of long 3 UTR BDNF mRNA in spine morphology and synaptic plasticity in hippocampal neurons. Cell 134(1), 175187 (2008).

Article CAS PubMed PubMed Central Google Scholar

Gruber, A. R. et al. Global 3 UTR shortening has a limited effect on protein abundance in proliferating T cells. Nat. Commun. 5, 5465 (2014).

Article ADS CAS PubMed Google Scholar

Magee, P., Shi, L. & Garofalo, M. Role of microRNAs in chemoresistance. Ann. Transl. Med. 3(21), 332 (2015).

PubMed PubMed Central Google Scholar

Tanaka, I. Regulation of alternative splicing and polyadenylation by genotoxic anti-cancer agents. Universit Paris-Saclay (2019).

Cole, S. P. C. Targeting multidrug resistance protein 1 (MRP1, ABCC1): Past, present, and future. Annu. Rev. Pharmacol. Toxicol. 54(1), 95117 (2014).

Article CAS PubMed Google Scholar

Hipfner, D. R. et al. Monoclonal antibodies that inhibit the transport function of the 190-kDa multidrug resistance protein, MRP. Localization of their epitopes to the nucleotide-binding domains of the protein. J. Biol. Chem. 274(22), 1542015426 (1999).

Article CAS PubMed Google Scholar

Emmanouilidi, A. et al. Inhibition of the lysophosphatidylinositol transporter ABCC1 reduces prostate cancer cell growth and sensitizes to chemotherapy. Cancers (Basel) 12(8), 2022 (2020).

Article CAS PubMed Google Scholar

Fanelli, M. et al. Targeting ABCB1 and ABCC1 with their specific inhibitor CBT-1 can overcome drug resistance in osteosarcoma. Curr. Cancer Drug Targets 16(3), 261274 (2016).

Article MathSciNet CAS PubMed Google Scholar

Stefan, S. M. Multi-target ABC transporter modulators: What next and where to go?. Future Med. Chem. 11(18), 23532358 (2019).

Article CAS PubMed Google Scholar

Schumacher, T. et al. ABC transporters B1, C1 and G2 differentially regulate neuroregeneration in mice. PLOS ONE 7(4), e35613 (2012).

Article ADS CAS PubMed PubMed Central Google Scholar

Galluzzi, L. et al. Molecular mechanisms of cell death: Recommendations of the Nomenclature Committee on Cell Death 2018. Cell Death Differ. 25(3), 486541 (2018).

Article PubMed PubMed Central Google Scholar

Basuli, D. et al. Iron addiction: A novel therapeutic target in ovarian cancer. Oncogene 36(29), 40894099 (2017).

Article CAS PubMed PubMed Central Google Scholar

Li, D., Zhang, M. & Chao, H. Significance of glutathione peroxidase 4 and intracellular iron level in ovarian cancer cellsutilization of ferroptosis mechanism. Inflamm. Res. 70(10), 11771189 (2021).

Article CAS PubMed Google Scholar

Chen, L. et al. Erastin sensitizes glioblastoma cells to temozolomide by restraining xCT and cystathionine--lyase function. Oncol. Rep. 33(3), 14651474 (2015).

Article MathSciNet CAS PubMed Google Scholar

Yamaguchi, H. et al. Caspase-independent cell death is involved in the negative effect of EGF receptor inhibitors on cisplatin in non-small cell lung cancer cells. Clin. Cancer Res: Off. J. Am. Assoc. Cancer Res. 19(4), 845854 (2013).

Article CAS Google Scholar

Zhou, H.-H. et al. Erastin reverses ABCB1-mediated docetaxel resistance in ovarian cancer. Front. Oncol. 9, 13981398 (2019).

Article PubMed PubMed Central Google Scholar

Beaufort, C. M. et al. Ovarian cancer cell line panel (OCCP): Clinical importance of in vitro morphological subtypes. PLOS ONE 9(9), e103988 (2014).

Article ADS PubMed PubMed Central Google Scholar

Perets, R. et al. Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in Brca;Tp53;Pten models. Cancer cell 24(6), 751765 (2013).

Article CAS PubMed PubMed Central Google Scholar

Klotz, D. M. & Wimberger, P. Cells of origin of ovarian cancer: Ovarian surface epithelium or fallopian tube?. Arch. Gynecol. Obstet. 296(6), 10551062 (2017).

Article PubMed Google Scholar

Soong, T. R. et al. The fallopian tube, precursor escape and narrowing the knowledge gap to the origins of high-grade serous carcinoma. Gynecol. Oncol. 152(2), 426433 (2019).

Article PubMed Google Scholar

Ducie, J. et al. Molecular analysis of high-grade serous ovarian carcinoma with and without associated serous tubal intra-epithelial carcinoma. Nat. Commun. 8(1), 990 (2017).

Article ADS PubMed PubMed Central Google Scholar

Masamha, C. P. & Todd, Z. Adapting 3 rapid amplification of CDNA ends to map transcripts in cancer. J. Vis. Exp. 133, e57318 (2018).

Google Scholar

Bruhn, O. et al. Alternative polyadenylation of ABC-transporters of the C-family (ABCC1, ABCC2, ABCC3) and implications on post-transcriptional micro-RNA regulation. Mol. Pharmacol. 97, 112122 (2019).

Article PubMed Google Scholar

Kurnit, K. C., Fleming, G. F. & Lengyel, E. Updates and new options in advanced epithelial ovarian cancer treatment. Obstet. Gynecol. 137(1), 108 (2021).

Article CAS PubMed Google Scholar

Gao, B. et al. Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer. Sci. Rep. 4, 4669 (2014).

Article CAS PubMed PubMed Central Google Scholar

Mayr, C. Regulation by 3-untranslated regions. Annu. Rev. Genetics 51(1), 171194 (2017).

Article CAS Google Scholar

Friedman, R. C. et al. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 19(1), 92105 (2009).

Article CAS PubMed PubMed Central Google Scholar

Mayr, C. & Bartel, D. P. Widespread shortening of 3UTRs by alternative cleavage and polyadenylation activates oncogenes in cancer cells. Cell 138(4), 673684 (2009).

Article CAS PubMed PubMed Central Google Scholar

Masamha, C. P. et al. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression. Nature 510(7505), 412416 (2014).

Article ADS CAS PubMed PubMed Central Google Scholar

He, X.-J. et al. Aberrant alternative polyadenylation is responsible for survivin up-regulation in ovarian cancer. Chin. Med. J. 129(10), 11401146 (2016).

Article CAS PubMed PubMed Central Google Scholar

Patch, A.-M. et al. Wholegenome characterization of chemoresistant ovarian cancer. Nature 521(7553), 489494 (2015).

Article ADS CAS PubMed Google Scholar

Chen, M. et al. miR-133b down-regulates ABCC1 and enhances the sensitivity of CRC to anti-tumor drugs. Oncotarget 8(32), 5298352994 (2017).

Article PubMed PubMed Central Google Scholar

Ma, J. et al. Involvement of miR-133a and miR-326 in ADM resistance of HepG2 through modulating expression of ABCC1. J. Drug Target 23(6), 519524 (2015).

More:
The role and impact of alternative polyadenylation and miRNA ... - Nature.com